🇺🇸 CHLOROQUINE HYDROCHLORIDE in United States

FDA authorised CHLOROQUINE HYDROCHLORIDE on 31 October 1949

Marketing authorisations

FDA — authorised 31 October 1949

  • Application: NDA006002
  • Marketing authorisation holder: SANOFI AVENTIS US
  • Local brand name: ARALEN HYDROCHLORIDE
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA

  • Status: approved

CHLOROQUINE HYDROCHLORIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is CHLOROQUINE HYDROCHLORIDE approved in United States?

Yes. FDA authorised it on 31 October 1949; FDA has authorised it.

Who is the marketing authorisation holder for CHLOROQUINE HYDROCHLORIDE in United States?

SANOFI AVENTIS US holds the US marketing authorisation.